Cannabis and classic psychedelics are controlled substances with emerging evidence of
efficacy in the treatment of a variety of psychiatric illnesses. Cannabis has largely not been …

This narrative review explores the utilization of psychedelic states in therapeutic contexts,
deliberately shifting the focus from psychedelic substances back to the experiential …

Background A dissociative subtype of posttraumatic stress disorder, known as “D-PTSD”,
has been included in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition …

Approximately 200 million people consume cannabis annually, with a significant proportion
of them using it chronically. Using experience sampling, we describe the effects of …

Clinical trials support the promise of psychedelic-assisted therapy (PAT) and reveal potential
mechanisms underlying efficacy. Out of necessity, initial studies of PAT have focused on …

Dysfunctional attitudes–a cornerstone to cognitive psychotherapy–vary with both
psychological and pharmacological interventions. Post-acute changes in these cognitions …

Chronic loneliness is a risk factor for physical and health problems, in part due to
dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis and sympathetic nervous …

This narrative review explores the utilization of psychedelic states in therapeutic contexts,
deliberately shifting the focus from psychedelic substances back to the experiential …